(Q48076623)

English

Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapy

scientific article published on 7 August 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Qingfeng Cheng

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Shumin Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Changhong Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Zhihong Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Zhengping Feng

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Rong Li

6

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Peng Ye

7

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Suhua Zhang

8

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Huacong Deng

9

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Bo Zhou

10

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Jian Long

11

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Lilin Gong

12

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Hua Qing

13

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Cheng Luo

14

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Qifu Li

15

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

publication date

7 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Journal of diabetes

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

7

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

2

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

182-191

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

The disposition index: from individual to population approach

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

β-cell function preservation after 3.5 years of intensive diabetes therapy

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Hyperglycemic crises in adult patients with diabetes

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Initial combination with linagliptin and metformin in newly diagnosed type 2 diabetes and severe hyperglycemia

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Short-term intensive insulin therapy in newly diagnosed type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12167

21 January 2018

Identifiers

10.1111/1753-0407.12167

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/24823280

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48076623&oldid=2184043143"